February 10, 2022 — Esaote North America, Inc. announced the FDA approval of the Magnifico Open MRI, a new open whole-body MRI system now available for purchase in the USA. The MagnificoOpen, was designed with the user in mind through customer feedback to bridge the gap between traditional musculoskeletal imaging and whole-body imaging.
The Magnifico Open is equipped with new advanced technologies that offer versatility in imaging across a wide range of clinical applications:
- Speed Up - Helps ensure optimal diagnostic image quality and reduce examination times.
- True-Motion – Innovative real-time imaging solution of the joint, ideal for sports medicine injuries.
- Metal Artifact Reduction (MAR) - Generates excellent image quality for post-surgical patients with metal implants.
“The Magnifico Open is designed for patient comfort,” said Stephen Gibbs, Manager of MRI Sales and Marketing for Esaote North America. “With an open-gantry design it is ideal for imaging children, large and claustrophobic patients. The compact size is uniquely suited for hospitals, imaging centers, and in-office clinics.”
“As MRI backlogs continue to rise, the demand for high-performance MRI is at an all-time high”, said Robert Lewis, President and General Manager of Esaote North America. “Now is the right time to bring open whole-body MRI to the US market, to help ease these scheduling challenges, while freeing up time slots on overloaded systems to accommodate more patients at the point of care.”
Drawing upon a 30-year legacy, Esaote continues to stay at the forefront, delivering cost-effective and eco-friendly diagnostic imaging solutions that meet the clinical and financial demands of customers worldwide.
For more information: www.esaote.com
July 25, 2024 
